Biography of Harvey Berger
Last update: April 8, 2024Career
Harvey was Chief Executive Officer and Chairman of the Board at ARIAD Pharmaceuticals, and Executive Chairman of the Board at Medinol. Harvey Berger joined Kojin Therapeutics in 2024.
Harvey Berger is currently Chairman of the Board, President and Chief Executive Officer at Kojin Therapeutics - View - Kojin Therapeutics org chart
Create your alert
to follow the career of Harvey Berger.
Education
Harvey Berger has a Bachelor of Science in Biochemistry from Colgate University in 1972 and a Medical Doctor from Yale University - School of Medicine in 1977.
They have also studied at Colgate University :
Find more alumni from Colgate University
They have also studied at Yale University - School of Medicine :
- Vishal Agrawal - Humana
- Yael Margolin - Scinai Immunotherapeutics
- Mittie Doyle - Aro Biotherapeutics
Find more alumni from Yale University - School of Medicine
More about Harvey Berger
Selected links
Do you need to know more about Harvey Berger? More results.
Participate
Social media
- Harvey Berger on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Harvey Berger
The colleagues of Harvey Berger
Company Colleagues
- At Kojin Therapeutics, Harvey Berger has 12 colleagues including Stuart Schreiber (Director), Gini Deshpande (Director)…
Industry Colleagues
- In the Biotechnology industry, Harvey Berger has 30,402 colleagues in 2,290 companies located in 40 countries. 14,379 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Harvey Berger.
